Screener
BridgeBio Pharma BBIO Reportable Segment — Gain (Loss) on Extinguishment of Debt
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Interest income | 6,246 | 5,385 |
| Interest expense | (12,942) | (18,121) |
| Noncash interest expense on deferred royalty obligations (1) | (39,873) | (24,020) |
| Loss on extinguishment of debt | — | (21,155) |
| Net loss from equity method investments | (18,283) | (15,556) |
| Other income, net | 4,253 | 8,231 |
| Total other expense, net | (60,599) | (65,236) |
| Net loss | (166,555) | (169,608) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's reportable segment — gain (loss) on extinguishment of debt?
- BridgeBio Pharma (BBIO) reported reportable segment — gain (loss) on extinguishment of debt of $0 in Q1 2026.
- How has BridgeBio Pharma's reportable segment — gain (loss) on extinguishment of debt changed year-over-year?
- BridgeBio Pharma's reportable segment — gain (loss) on extinguishment of debt increased by 100.0% year-over-year, from -$21.16M to $0.
- What does reportable segment — gain (loss) on extinguishment of debt mean?
- This metric represents the gain or loss recognized when the company retires debt obligations before their scheduled maturity date. It reflects the difference between the reacquisition price and the net carrying amount of the debt extinguished. This is a non-operating item that highlights the financial impact of capital structure optimization or refinancing activities.
Ask your AI about BridgeBio Pharma's reportable segment — gain (loss) on extinguishment of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude